Methyl 3-bromo-1H-indazole-6-carboxylate

Catalog No. :
ACKPIT970
CAS No. :
192945-56-5
Molecular Formula :
C9H7BrN2O2
Molecular Weight :
255.07

IUPAC Name:methyl 3-bromo-1H-indazole-6-carboxylate

Methyl 3-bromo-1H-indazole-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$60.00Login to see priceIn stockIn stock
10g97%$111.00Login to see priceIn stockIn stock
25g97%$223.00Login to see priceIn stockInquiry
100g97%$865.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-bromo-1H-indazole-6-carboxylate
IUPAC Namemethyl 3-bromo-1H-indazole-6-carboxylate
MDL No.MFCD11499017
Molecular FormulaC9H7BrN2O2
Molecular Weight255.07
SMILESO=C(C1=CC2=C(C=C1)C(Br)=NN2)OC
InChI KeyNXMJEXMODINMIJ-UHFFFAOYSA-N
Synonym192945-56-5 | methyl 3-bromo-1H-indazole-6-carboxylate | METHYL 3-BROMOINDAZOLE-6-CARBOXYLATE | methyl 3-bromo-2H-indazole-6-carboxylate | 1h-indazole-6-carboxylic acid,3-bromo-,methyl ester | MFCD11499017 | SCHEMBL348514 | 3-bromo-2H-indazole-6-carboxylic acid methyl
CAS No.192945-56-5
PubChem CID18388154

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKPIT970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKZXG837 route compound structure diagram
    ACKZXG837170487-40-8 In Stock
  2. Then
  3. ACKPIT970 route product structure diagram
    ACKPIT970192945-56-5 In Stock
Inquiry

2. ACKPIT970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKZXG837 route compound structure diagram
    ACKZXG837170487-40-8 In Stock
  4. Then
  5. ACKPIT970 route product structure diagram
    ACKPIT970192945-56-5 In Stock
Inquiry

Comments (0)